Patents by Inventor Pradeep Dinesh Shahi

Pradeep Dinesh Shahi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240376175
    Abstract: The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1)(7-37) analogs having an amino acid sequence with Leu or Ile at the C-terminal. The new analogs are potent GLP-1 agonists with reduced adverse effect and improved duration of action. The present disclosure further relates to acylated derivatives of the new analogs which have further improved potency and duration of action and are suitable for oral administration. The analogs of present disclosure may be useful in treatment of diabetes and obesity.
    Type: Application
    Filed: May 17, 2024
    Publication date: November 14, 2024
    Inventors: Rajamannar Thennati, Nishith Chaturvedi, Vinod Sampatrao Burade, Pradeep Dinesh Shahi, Muthukumaran Natarajan, Ravishankara Madavati Nagaraja, Rishit Mansukhlal Zalawadia, Vipulkumar Shankarbhai Patel, Kunal Pandya, Brijeshkumar Patel, Dhiren Rameshchandra Joshi, Krunal Harishbhai Soni, Abhishek Tiwari
  • Publication number: 20240199718
    Abstract: The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1) (7-37) analogs having an amino acid sequence with Leu or Ile at the C-terminal. The new analogs are potent GLP-1 agonists with reduced adverse effect and improved duration of action. The present disclosure further relates to acylated derivatives of the new analogs which have further improved potency and duration of action and are suitable for oral administration. The analogs of present disclosure may be useful in treatment of diabetes and obesity.
    Type: Application
    Filed: November 21, 2023
    Publication date: June 20, 2024
    Inventors: Rajamannar Thennati, Nishith Chaturvedi, Vinod Sampatrao Burade, Pradeep Dinesh Shahi, Muthukumaran Natarajan, Ravishankara Madavati Nagaraja, Rishit Mansukhlal Zalawadia, Vipulkumar Shankarbhai Patel, Kunal Pandya, Brijeshkumar Patel, Dhiren Rameshchandra Joshi, Krunal Harishbhai Soni, Abhishek Tiwari
  • Patent number: 11873328
    Abstract: The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1) (7-37) analogs having an amino acid sequence with Leu or Ile at the C-terminal. The new analogs are potent GLP-1 agonists with reduced adverse effect and improved duration of action. The present disclosure further relates to acylated derivatives of the new analogs which have further improved potency and duration of action and are suitable for oral administration. The analogs of present disclosure may be useful in treatment of diabetes and obesity.
    Type: Grant
    Filed: August 1, 2022
    Date of Patent: January 16, 2024
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Rajamannar Thennati, Nishith Chaturvedi, Vinod Sampatrao Burade, Pradeep Dinesh Shahi, Muthukumaran Natarajan, Ravishankara Madavati Nagaraja, Rishit Mansukhlal Zalawadia, Vipulkumar Shankarbhai Patel, Kunal Pandya, Brijeshkumar Patel, Dhiren Rameshchandra Joshi, Krunal Harishbhai Soni, Abhishek Tiwari
  • Patent number: 11866477
    Abstract: The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1) (7-37) analogs having an amino acid sequence with Leu or Ile at the C-terminal. The new analogs are potent GLP-1 agonists with reduced adverse effect and improved duration of action. The present disclosure further relates to acylated derivatives of the new analogs which have further improved potency and duration of action and are suitable for oral administration. The analogs of present disclosure may be useful in treatment of diabetes and obesity.
    Type: Grant
    Filed: August 12, 2022
    Date of Patent: January 9, 2024
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Rajamannar Thennati, Nishith Chaturvedi, Vinod Sampatrao Burade, Pradeep Dinesh Shahi, Muthukumaran Natarajan, Ravishankara Madavati Nagaraja, Rishit Mansukhlal Zalawadia, Vipulkumar Shankarbhai Patel, Kunal Pandya, Brijeshkumar Patel, Dhiren Rameshchandra Joshi, Krunal Harishbhai Soni, Abhishek Tiwari
  • Publication number: 20220402991
    Abstract: The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1) (7-37) analogs having an amino acid sequence with Leu or Ile at the C-terminal. The new analogs are potent GLP-1 agonists with reduced adverse effect and improved duration of action. The present disclosure further relates to acylated derivatives of the new analogs which have further improved potency and duration of action and are suitable for oral administration. The analogs of present disclosure may be useful in treatment of diabetes and obesity.
    Type: Application
    Filed: August 1, 2022
    Publication date: December 22, 2022
    Inventors: Rajamannar Thennati, Nishith Chaturvedi, Vinod Sampatrao Burade, Pradeep Dinesh Shahi, Muthukumaran Natarajan, Ravishankara Madavati Nagaraja, Rishit Mansukhlal Zalawadia, Vipulkumar Shankarbhai Patel, Kunal Pandya, Brijeshkumar Patel, Dhiren Rameshchandra Joshi, Krunal Harishbhai Soni, Abhishek Tiwari
  • Publication number: 20220402992
    Abstract: The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1) (7-37) analogs having an amino acid sequence with Leu or Ile at the C-terminal. The new analogs are potent GLP-1 agonists with reduced adverse effect and improved duration of action. The present disclosure further relates to acylated derivatives of the new analogs which have further improved potency and duration of action and are suitable for oral administration. The analogs of present disclosure may be useful in treatment of diabetes and obesity.
    Type: Application
    Filed: August 12, 2022
    Publication date: December 22, 2022
    Inventors: Rajamannar Thennati, Nishith Chaturvedi, Vinod Sampatrao Burade, Pradeep Dinesh Shahi, Muthukumaran Natarajan, Ravishankara Madavati Nagaraja, Rishit Mansukhlal Zalawadia, Vipulkumar Shankarbhai Patel, Kunal Pandya, Brijeshkumar Patel, Dhiren Rameshchandra Joshi, Krunal Harishbhai Soni, Abhishek Tiwari
  • Patent number: 11485766
    Abstract: The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1) (7-37) analogs having an amino acid sequence with Leu or Ile at the C-terminal. The new analogs are potent GLP-1 agonists with reduced adverse effect and improved duration of action. The present disclosure further relates to acylated derivatives of the new analogs which have further improved potency and duration of action and are suitable for oral administration. The analogs of present disclosure may be useful in treatment of diabetes and obesity.
    Type: Grant
    Filed: December 28, 2020
    Date of Patent: November 1, 2022
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Rajamannar Thennati, Nishith Chaturvedi, Vinod Sampatrao Burade, Pradeep Dinesh Shahi, Muthukumaran Natarajan, Ravishankara Madavati Nagaraja, Rishit Mansukhlal Zalawadia, Vipulkumar Shankarbhai Patel, Kunal Pandya, Brijeshkumar Patel, Dhiren Rameshchandra Joshi, Krunal Harishbhai Soni, Abhishek Tiwari
  • Patent number: 11447535
    Abstract: The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1) (7-37) analogs having an amino acid sequence with Leu or Ile at the C-terminal. The new analogs are potent GLP-1 agonists with reduced adverse effect and improved duration of action. The present disclosure further relates to acylated derivatives of the new analogs which have further improved potency and duration of action and are suitable for oral administration. The analogs of present disclosure may be useful in treatment of diabetes and obesity.
    Type: Grant
    Filed: April 5, 2019
    Date of Patent: September 20, 2022
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Rajamannar Thennati, Nishith Chaturvedi, Vinod Sampatrao Burade, Pradeep Dinesh Shahi, Muthukumaran Natarajan, Ravishankara Madavati Nagaraja, Rishit Mansukhlal Zalawadia, Vipulkumar Shankarbhai Patel, Kunal Pandya, Brijeshkumar Patel, Dhiren Rameshchandra Joshi, Krunal Harishbhai Soni, Abhishek Tiwari
  • Patent number: 11242373
    Abstract: The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1) (7-37) analogs having an amino acid sequence with Leu or Ile at the C-terminal. The new analogs are potent GLP-1 agonists with reduced adverse effect and improved duration of action. The present disclosure further relates to acylated derivatives of the new analogs which have further improved potency and duration of action and are suitable for oral administration. The analogs of present disclosure may be useful in treatment of diabetes and obesity.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: February 8, 2022
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Rajamannar Thennati, Nishith Chaturvedi, Vinod Sampatrao Burade, Pradeep Dinesh Shahi, Muthukumaran Natarajan, Ravishankara Madavati Nagaraja, Rishit Mansukhlal Zalawadia, Vipulkumar Shankarbhai Patel, Kunal Pandya, Brijeshkumar Patel, Dhiren Rameshchandra Joshi, Krunal Harishbhai Soni, Abhishek Tiwari
  • Publication number: 20210206823
    Abstract: The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1) (7-37) analogs having an amino acid sequence with Leu or Ile at the C-terminal. The new analogs are potent GLP-1 agonists with reduced adverse effect and improved duration of action. The present disclosure further relates to acylated derivatives of the new analogs which have further improved potency and duration of action and are suitable for oral administration. The analogs of present disclosure may be useful in treatment of diabetes and obesity.
    Type: Application
    Filed: December 28, 2020
    Publication date: July 8, 2021
    Inventors: Rajamannar Thennati, Nishith Chaturvedi, Vinod Sampatrao Burade, Pradeep Dinesh Shahi, Muthukumaran Natarajan, Ravishankara Madavati Nagaraja, Rishit Mansukhlal Zalawadia, Vipulkumar Shankarbhai Patel, Kunal Pandya, Brijeshkumar Patel, Dhiren Rameshchandra Joshi, Krunal Harishbhai Soni, Abhishek Tiwari
  • Patent number: 11046744
    Abstract: The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1) (7-37) analogs having an amino acid sequence with Leu or Ile at the C-terminal. The new analogs are potent GLP-1 agonists with reduced adverse effect and improved duration of action. The present disclosure further relates to acylated derivatives of the new analogs which have further improved potency and duration of action and are suitable for oral administration. The analogs of present disclosure may be useful in treatment of diabetes and obesity.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: June 29, 2021
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Rajamannar Thennati, Nishith Chaturvedi, Vinod Sampatrao Burade, Pradeep Dinesh Shahi, Muthukumaran Natarajan, Ravishankara Madavati Nagaraja, Rishit Mansukhlal Zalawadia, Vipulkumar Shankarbhai Patel, Kunal Pandya, Brijeshkumar Patel, Dhiren Rameshchandra Joshi, Krunal Harishbhai Soni, Abhishek Tiwari
  • Publication number: 20200362007
    Abstract: The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1) (7-37) analogs having an amino acid sequence with Leu or Ile at the C-terminal. The new analogs are potent GLP-1 agonists with reduced adverse effect and improved duration of action. The present disclosure further relates to acylated derivatives of the new analogs which have further improved potency and duration of action and are suitable for oral administration. The analogs of present disclosure may be useful in treatment of diabetes and obesity.
    Type: Application
    Filed: August 4, 2020
    Publication date: November 19, 2020
    Inventors: Rajamannar Thennati, Nishith Chaturvedi, Vinod Sampatrao Burade, Pradeep Dinesh Shahi, Muthukumaran Natarajan, Ravishankara Madavati Nagaraja, Rishit Mansukhlal Zalawadia, Vipulkumar Shankarbhai Patel, Kunal Pandya, Brijeshkumar Patel, Dhiren Rameshchandra Joshi, Krunal Harishbhai Soni, Abhishek Tiwari
  • Publication number: 20190309040
    Abstract: The present disclosure pertains to novel Glucagon like Peptide-1 (GLP-1) (7-37) analogs having an amino acid sequence with Leu or Ile at the C-terminal. The new analogs are potent GLP-1 agonists with reduced adverse effect and improved duration of action. The present disclosure further relates to acylated derivatives of the new analogs which have further improved potency and duration of action and are suitable for oral administration. The analogs of present disclosure may be useful in treatment of diabetes and obesity.
    Type: Application
    Filed: April 5, 2019
    Publication date: October 10, 2019
    Inventors: Rajamannar Thennati, Nishith Chaturvedi, Vinod Sampatrao Burade, Pradeep Dinesh Shahi, Muthukumaran Natarajan, Ravishankara Madavati Nagaraja, Rishit Mansukhlal Zalawadia, Vipulkumar Shankarbhai Patel, Kunal Pandya, Brijeshkumar Patel, Dhiren Rameshchandra Joshi, Krunal Harishbhai Soni, Abhishek Tiwari